Replies to post #414388 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

The beef in my opinion:

Alzheimer’s disease: Full data ANAVEX®2-73-AD-004, including newly available preliminary results of surrogate biomarkers of pivotal Phase 2b/3 clinical trial. The Company intends to discuss these findings with regulatory authorities in the context of the ongoing clinical development of ANAVEX®2-73 in this indication, with the goal of providing a much-needed treatment to the millions of patients living with Alzheimer’s disease with a convenient once-daily oral treatment. The Company plans to proceed in parallel with the initiation of a confirmatory Alzheimer’s disease study.

We will now be on the hands of the FDA for AA.

Along side we will be running the confirmatory P3 it sounds like, no matter what the FDA says.